{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:51:15Z","timestamp":1787849475642,"version":"build-2784847793"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.amjmed.2020.10.018","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T21:51:31Z","timestamp":1604872291000},"page":"e308-e312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antimycotic Treatment of Oral Candidiasis in Warfarin Users"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-9091","authenticated-orcid":false,"given":"Ditte B.","family":"Iversen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-420X","authenticated-orcid":false,"given":"Maja","family":"Hellfritzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-4389","authenticated-orcid":false,"given":"Tore B.","family":"Stage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune M.","family":"Aabenhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent S.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-5679","authenticated-orcid":false,"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.amjmed.2020.10.018_bib0001","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/CIRCULATIONAHA.112.100628","article-title":"Warfarin pharmacogenetics: a rising tide for its clinical value","volume":"125","author":"Johnson","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.amjmed.2020.10.018_bib0002","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2020.10.018_bib0003","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bcpt.12722","article-title":"Topical antimycotics for oral candidiasis in warfarin users","volume":"120","author":"Hellfritzsch","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.amjmed.2020.10.018_bib0004","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.4317\/jced.51798","article-title":"Current treatment of oral candidiasis: a literature review","volume":"6","author":"Garcia-Cuesta","year":"2014","journal-title":"J Clin Exp Dent"},{"issue":"1","key":"10.1016\/j.amjmed.2020.10.018_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2710.2011.01246.x","article-title":"Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin","volume":"37","author":"Kovac","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.amjmed.2020.10.018_bib0006","doi-asserted-by":"crossref","unstructured":"Engell AE, Svendsen ALO, Lind BS, et al. Drug-drug interaction between warfarin and statins: a Danish cohort study [e-pub ahead of print]. Br J Clin Pharmacol. Accessed April 4, 2020.","DOI":"10.1111\/bcp.14428"},{"issue":"3","key":"10.1016\/j.amjmed.2020.10.018_bib0007","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"9025","key":"10.1016\/j.amjmed.2020.10.018_bib0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.amjmed.2020.10.018_bib0009","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/bpb.28.1805","article-title":"Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes","volume":"28","author":"Niwa","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"9-10","key":"10.1016\/j.amjmed.2020.10.018_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1439-0507.1996.tb00149.x","article-title":"Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk","volume":"39","author":"Schafer-Korting","year":"1996","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.amjmed.2020.10.018_bib0011","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cpt.1662","article-title":"Ischemic stroke and systemic embolism in warfarin users with atrial fibrillation or heart valve replacement exposed to dicloxacillin or flucloxacillin","volume":"107","author":"Hellfritzsch","year":"2020","journal-title":"Clin Pharmacol Ther"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432030958X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432030958X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:24:31Z","timestamp":1757582671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293432030958X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S000293432030958X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.10.018","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimycotic Treatment of Oral Candidiasis in Warfarin Users","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}